Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript
Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.12.
Dare Bioscience Inc. (DARE)
Market is closed
News
- Displaying 10
Daré Bioscience, Inc. (NASDAQ:DARE) Q3 2023 Earnings Call Transcript
Operator: Welcome to the conference hosted by Daré Bioscience to Review the Company's Third Quarter Financial Results and to provide a General Business Update. This call is being recorded.
Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2023 Earnings Call Transcript
Operator: Welcome to the conference hosted by Daré Bioscience to review the Company’s Financial Results for the Quarter Ended June 30, 2023, and to provide a General Business Update.
Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2023 Earnings Call Transcript
Operator: Welcome to the conference call hosted by Daré Bioscience to review the Company’s Financial Results for the Quarter Ended March 31, 2023, and to provide a General Business Update.
Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2022 Earnings Call Transcript
Operator: Welcome to the conference call hosted by Daré Bioscience to review the company's Financial Results for the Year Ended December 31, 2022 and to provide a general business update.
15 Best High Volume Penny Stocks to Buy Now
Penny stocks had become an important indicator of the overall health of the stock market in the past few years as zealous retail investor interest and a record surge in the prices of risky assets like...
5 Penny Stocks to Buy in December
Daré Bioscience, Inc. (NASDAQ:DARE) is a clinical-stage biopharma firm focusing on products related to the health of women.
Is Dare Bioscience, Inc. (DARE) A Good Stock To Buy?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Hedge Fund and Insider Trading News: Keith Meister, Jeffrey Smith, Highland Capital, Dare Bioscience Inc (DARE), Quest Resource Holding Corp (QRHC), KAR Auction Services Inc (KAR), and More
Shares of Cerner are up 20% this year but the medical records company can still rise much further as it is still cheap, activist investor Jeff Smith said Tuesday.
Market Movers Today: Chegg Inc (CHGG), Helios and Matheson Analytics Inc (HMNY), Blue Apron Holdings Inc (APRN), and More
What happened: shares of Chegg Inc. (NYSE:CHGG) jumped on Tuesday after the connected learning platform provider reported its fourth-quarter results.
Billionaire Hedge Funds
